EMA: Draft GL for OIPs [BE/BA News]

posted by Ohlbe – France, 2024-04-22 16:07 (233 d 13:50 ago) – Posting: # 23961
Views: 2,040

Dear Chirag,

❝ Since this is my first post, I apologize for any errors.


No error, and welcome to the forum.

❝ Upon reading, I noticed that the recently introduced guidelines still relate to Directive 2001/20/EC rather than 536/2014.


You're absolutely right, the guideline should refer to the Clinical Trial Regulation and no longer to the Clinical Trial Directive. There was a first public consultation to revise this guideline in 2017 (before the CTR came into force), and it looks like they failed to update this paragraph after that.

The document just published is again a draft for public consultation. Hopefully this will be pointed out and corrected.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,666 registered users;
32 visitors (0 registered, 32 guests [including 9 identified bots]).
Forum time: 04:57 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5